Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence

Since the emergence of the novel coronavirus, named COVID-19, researchers are looking for a treatment to stop the devastating pandemic. During these efforts, mesenchymal stem cells (MSCs), the potential next generation of therapeutic methods with wide application for diseases, have successfully cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiaie, Nasim, Ghanavati, Seyedeh Parvin Mousavi, Miremadi, Sara Sadat, Hadipour, Azam, Aghdam, Rouhollah Mehdinavaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429942/
https://www.ncbi.nlm.nih.gov/pubmed/34158414
http://dx.doi.org/10.15283/ijsc20182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429942/
https://www.ncbi.nlm.nih.gov/pubmed/34158414
http://dx.doi.org/10.15283/ijsc20182

Ejemplares similares